Memantine Use and Cognitive Decline in Huntington's Disease: An Enroll‐HD Study

Memantine is an N‐methyl‐d‐aspartate (NMDA) receptor antagonist that is used to treat moderate to severe Alzheimer's Dementia (AD) and has been speculated to provide clinical benefits in Huntington's disease (HD).

[1]  R. Reilmann,et al.  Association of CAG Repeats With Long-term Progression in Huntington Disease. , 2019, JAMA neurology.

[2]  G. Casadesus,et al.  Memantine for the Treatment of Dementia: A Review on its Current and Future Applications , 2017, Journal of Alzheimer's disease : JAD.

[3]  J. Stout,et al.  Data Analytics from Enroll‐HD, a Global Clinical Research Platform for Huntington's Disease , 2017, Movement Disorders Clinical Practice.

[4]  P. Maher,et al.  Chronic Glutamate Toxicity in Neurodegenerative Diseases—What is the Evidence? , 2015, Front. Neurosci..

[5]  G. Grossberg,et al.  Use of memantine for the treatment of dementia , 2011, Expert review of neurotherapeutics.

[6]  Jane S. Paulsen,et al.  Indexing disease progression at study entry with individuals at‐risk for Huntington disease , 2011, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[7]  Gary King,et al.  MatchIt: Nonparametric Preprocessing for Parametric Causal Inference , 2011 .

[8]  L. Raymond,et al.  Early Increase in Extrasynaptic NMDA Receptor Signaling and Expression Contributes to Phenotype Onset in Huntington's Disease Mice , 2010, Neuron.

[9]  Kristen K. Ade,et al.  Differential Tonic GABA Conductances in Striatal Medium Spiny Neurons , 2008, The Journal of Neuroscience.

[10]  W. Ondo,et al.  A pilot study of the clinical efficacy and safety of memantine for Huntington's disease. , 2007, Parkinsonism & related disorders.

[11]  S. Lipton.  Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation. , 2007, Current drug targets.

[12]  J. Kemp,et al.  NMDA receptor pathways as drug targets , 2002, Nature Neuroscience.

[13]  Manish S. Shah,et al.  A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes , 1993, Cell.

[14]  F. Sherriff,et al.  Memantine for dementia. , 2005, The Cochrane database of systematic reviews.

[15]  P. Kirkpatrick,et al.  Fresh from the pipeline: Memantine hydrochloride , 2004 .

[16]  M. Gerlach,et al.  The N-methyl-D-aspartate antagonist memantine retards progression of Huntington's disease. , 2004, Journal of neural transmission. Supplementum.

[17]  H. Kremer.  Unified Huntington's disease rating scale: reliability and consistency , 1996 .

[18]  Poster Viewing , 2022 .